These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36844520)

  • 1. Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson's Disease.
    Prabhakaran P; Nadig A; M S; Tuladhar S; Raju RM; Chidambaram SB; Kempaiah BB; Raghavendra NM; Kumar Br P
    ACS Omega; 2023 Feb; 8(7):6825-6837. PubMed ID: 36844520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders.
    Justin A; Mandal S; Prabitha P; Dhivya S; Yuvaraj S; Kabadi P; Sekhar SJ; Sandhya CH; Wadhwani AD; Divakar S; Bharathi JJ; Durai P; Prashantha Kumar BR
    Neurotox Res; 2020 Mar; 37(3):508-524. PubMed ID: 31782098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics.
    P P; Justin A; Ananda Kumar TD; Chinaswamy M; Kumar BRP
    ACS Chem Neurosci; 2021 Jul; 12(13):2261-2272. PubMed ID: 34125534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating Brain Cytokines and Oxy-Radicals in ICV-LPS Neuroinflammatory Rat Model.
    Justin A; Ashwini P; Jose JA; Jeyarani V; Dhanabal SP; Manisha C; Mandal SP; Bhavimani G; Prabitha P; Yuvaraj S; Prashantha Kumar BR
    Front Neurosci; 2020; 14():530148. PubMed ID: 33100954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glitazones, PPAR-γ and Neuroprotection.
    Kumar AP; P P; Kumar BRP; Jeyarani V; Dhanabal SP; Justin A
    Mini Rev Med Chem; 2021; 21(12):1457-1464. PubMed ID: 33663364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
    Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
    Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-Lipoic Acid Attenuates MPTP/MPP
    Zhang J; Gao Y; Zhang L; Zhang C; Zhao Y; Zhang Y; Li S; Chang C; Zhang X; Yang G
    Neurotox Res; 2022 Apr; 40(2):410-419. PubMed ID: 35146598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
    Eschbach J; von Einem B; Müller K; Bayer H; Scheffold A; Morrison BE; Rudolph KL; Thal DR; Witting A; Weydt P; Otto M; Fauler M; Liss B; McLean PJ; Spada AR; Ludolph AC; Weishaupt JH; Danzer KM
    Ann Neurol; 2015 Jan; 77(1):15-32. PubMed ID: 25363075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) Activator Ameliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson's Disease.
    Das NR; Vaidya B; Khare P; Bishnoi M; Sharma SS
    Curr Neurovasc Res; 2021; 18(5):497-507. PubMed ID: 34923943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
    Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
    Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway.
    Ye Q; Ye L; Xu X; Huang B; Zhang X; Zhu Y; Chen X
    BMC Complement Altern Med; 2012 Jun; 12():82. PubMed ID: 22742579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity.
    Wang Y; Chen C; Huang W; Huang M; Wang J; Chen X; Ye Q
    Aging (Albany NY); 2019 Oct; 11(20):8937-8950. PubMed ID: 31634150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minutes of PPAR-γ agonism and neuroprotection.
    Prashantha Kumar BR; Kumar AP; Jose JA; Prabitha P; Yuvaraj S; Chipurupalli S; Jeyarani V; Manisha C; Banerjee S; Jeyabalan JB; Mohankumar SK; Dhanabal SP; Justin A
    Neurochem Int; 2020 Nov; 140():104814. PubMed ID: 32758586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.
    Wu P; Dong Y; Chen J; Guan T; Cao B; Zhang Y; Qi Y; Guan Z; Wang Y
    Neurotox Res; 2022 Feb; 40(1):286-297. PubMed ID: 35043376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorpyrifos activates cell pyroptosis and increases susceptibility on oxidative stress-induced toxicity by miR-181/SIRT1/PGC-1α/Nrf2 signaling pathway in human neuroblastoma SH-SY5Y cells: Implication for association between chlorpyrifos and Parkinson's disease.
    Zhao MW; Yang P; Zhao LL
    Environ Toxicol; 2019 Jun; 34(6):699-707. PubMed ID: 30835941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome Proliferator-Activated Receptor γ Coactivator 1α Activates Vascular Endothelial Growth Factor That Protects Against Neuronal Cell Death Following Status Epilepticus through PI3K/AKT and MEK/ERK Signaling.
    Huang JB; Hsu SP; Pan HY; Chen SD; Chen SF; Lin TK; Liu XP; Li JH; Chen NC; Liou CW; Hsu CY; Chuang HY; Chuang YC
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.
    Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB
    Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson's disease.
    Fan F; Li S; Wen Z; Ye Q; Chen X; Ye Q
    Aging (Albany NY); 2020 May; 12(10):9461-9474. PubMed ID: 32452827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson's disease model.
    Lee Y; Cho JH; Lee S; Lee W; Chang SC; Chung HY; Moon HR; Lee J
    Brain Res; 2019 Feb; 1704():47-58. PubMed ID: 30273550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.